Bausch Health Companies (BHC) Tax Provisions (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Tax Provisions came in at $77.0 million in Q1 2026, up 97.44% year-on-year from $39.0 million in Q1 2025, and down 51.57% quarter-over-quarter from $159.0 million in Q4 2025.
Bausch Health Companies (BHC) Tax Provisions (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Tax Provisions across 18 years of filings, most recently posting $77.0 million for Q1 2026.
- Tax Provisions for Q1 2026 came in at $77.0 million, up 97.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $285.0 million (up 5.56% YoY), and the FY2025 annual result was $247.0 million, up 3.35% from the prior year.
- Tax Provisions came in at $77.0 million for Q1 2026 at Bausch Health Companies, down from $159.0 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $159.0 million in Q4 2025 to a low of -$16.0 million in Q1 2022.
- The 5-year median for Tax Provisions is $49.0 million (2024), against an average of $51.0 million.
- Across the five-year window, Tax Provisions plunged 200.0% in 2022 and surged 556.25% in 2023, its largest moves.
- Bausch Health Companies' Tax Provisions stood at $53.0 million in 2022, then declined by 24.53% to $40.0 million in 2023, then jumped by 177.5% to $111.0 million in 2024, then jumped by 43.24% to $159.0 million in 2025, then plunged by 51.57% to $77.0 million in 2026.
- The last three Tax Provisions figures came in at $77.0 million (Q1 2026), $159.0 million (Q4 2025), and $37.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 67.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 157.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.40 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -3.57 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 48.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 30.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.60 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 37.99 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -9.44 Mn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | 77.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.00 Mn |
| Dec 31, 2025 | 159.00 Mn |
| Sep 30, 2025 | 37.00 Mn |
| Jun 30, 2025 | 12.00 Mn |
| Mar 31, 2025 | 39.00 Mn |
| Dec 31, 2024 | 111.00 Mn |
| Sep 30, 2024 | 71.00 Mn |
| Jun 30, 2024 | 49.00 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Sep 30, 2023 | 56.00 Mn |
| Jun 30, 2023 | 52.00 Mn |
| Mar 31, 2023 | 73.00 Mn |
| Dec 31, 2022 | 53.00 Mn |
| Sep 30, 2022 | 36.00 Mn |
| Jun 30, 2022 | 10.00 Mn |
| Mar 31, 2022 | -16.00 Mn |
| Dec 31, 2021 | -51.00 Mn |
| Sep 30, 2021 | 25.00 Mn |
| Jun 30, 2021 | -77.00 Mn |